BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10619519)

  • 21. Surgical treatment of non-small cell lung cancer: mediastinal lymph node dissection.
    Meacci E; Margaritora S; Cesario A; Porziella V; Kawamukai K; Piraino A; Vita ML; Tessitore A; Cusumano G; Granone P
    Rays; 2004; 29(4):423-9. PubMed ID: 15852730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Postoperative adjuvant therapy for 189 patients with completely resected non-small cell lung cancer of stage III(A)].
    Li Q; Gao JM; Liang PY; Xie FY; Liu GZ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1463-6. PubMed ID: 15566658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extent of removal for mediastinal nodal stations for patients with clinical stage I non-small cell lung cancer: effect on outcome.
    Jeon HW; Moon MH; Kim KS; Kim YD; Wang YP; Park HJ; Park JK
    Thorac Cardiovasc Surg; 2014 Oct; 62(7):599-604. PubMed ID: 24420680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Should aggressive surgery ever be part of the management of small cell lung cancer?
    Waddell TK; Shepherd FA
    Thorac Surg Clin; 2004 May; 14(2):271-81. PubMed ID: 15382303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of surgical resection of stage IIIa (N2) non small cell lung cancer, according to the site of the mediastinal metastases.
    Maggi G; Casadio C; Cianci R; Molinatti M; Filosso PL; Nicolosi M; Oliaro A
    Int Surg; 1993; 78(3):213-7. PubMed ID: 8276543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lobe-Specific Lymph Node Dissection as a Standard Procedure in Surgery for Non-Small Cell Lung Cancer: A Propensity Score Matching Study.
    Adachi H; Sakamaki K; Nishii T; Yamamoto T; Nagashima T; Ishikawa Y; Ando K; Yamanaka K; Watanabe K; Kumakiri Y; Tsuboi M; Maehara T; Nakayama H; Masuda M
    J Thorac Oncol; 2017 Jan; 12(1):85-93. PubMed ID: 27553515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer.
    Zhong W; Yang X; Bai J; Yang J; Manegold C; Wu Y
    Eur J Cardiothorac Surg; 2008 Jul; 34(1):187-95. PubMed ID: 18457958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Completeness of lung cancer surgery: is mediastinal dissection common practice?
    Verhagen AF; Schoenmakers MC; Barendregt W; Smit H; van Boven WJ; Looijen M; van der Heijden EH; van Swieten HA
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):834-8. PubMed ID: 22290900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
    Bunn PA
    Clin Lung Cancer; 2004 Sep; 6(2):85-98. PubMed ID: 15476594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term survivors with pN2 non-small cell lung cancer after a complete resection with a systematic mediastinal node dissection.
    Yano T; Fukuyama Y; Yokoyama H; Kuninaka S; Terazaki Y; Uehara T; Asoh H; Ichinose Y
    Eur J Cardiothorac Surg; 1998 Aug; 14(2):152-5. PubMed ID: 9755000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnosis and surgical treatment for stage I non-small-cell lung cancer].
    Gao YS; Zhang DC; He J; Sun KL; Zhang DW; Zhang RG
    Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):52-5. PubMed ID: 15771801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC.
    Pezzetta E; Stupp R; Zouhair A; Guillou L; Taffé P; von Briel C; Krueger T; Ris HB
    Eur J Cardiothorac Surg; 2005 Jun; 27(6):1092-8. PubMed ID: 15896624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of lymphadenectomy in lung cancer surgery.
    D'Andrilli A; Venuta F; Rendina EA
    Thorac Surg Clin; 2012 May; 22(2):227-37. PubMed ID: 22520290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-small-cell lung cancer restaging with transcervical extended mediastinal lymphadenectomy.
    Zieliński M; Hauer L; Hauer J; Nabiałek T; Szlubowski A; Pankowski J
    Eur J Cardiothorac Surg; 2010 Apr; 37(4):776-80. PubMed ID: 20044265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of neoadjuvant therapy in the treatment of locally advanced, stage III non-small-cell lung cancer].
    Balikó Z; Sárosi V
    Magy Onkol; 2005; 49(2):161-8. PubMed ID: 16249813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Surgical therapy of bronchial carcinoma].
    Skuballa A
    MMW Fortschr Med; 2007 Nov; 149(44):30-1. PubMed ID: 18078167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDG PET/CT for assessing the resectability of NSCLC patients with N2 disease after neoadjuvant therapy.
    Kremer R; Peysakhovich Y; Dan LF; Guralnik L; Kagna O; Nir RR; Bar-Shalom R
    Ann Nucl Med; 2016 Feb; 30(2):114-21. PubMed ID: 26613715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Surgical treatment of stage IIIA non-small-cell lung cancer].
    Porkhanov VA; Mova VS; Kononenko VB; Bodnia VN; Poliakov IS
    Vopr Onkol; 2000; 46(1):74-6. PubMed ID: 10789229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Relatively non-curative resection for lung cancer: is this a complete resection?].
    Nonaka M; Kadokura M; Yamamoto S; Kataoka D; Iyano K; Kawada T; Takaba T
    Kyobu Geka; 2000 Aug; 53(9):759-62. PubMed ID: 10935403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.